Question 1

What are the potential side effects of lasmiditan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine clinical trial (NCT04396574). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other migraine treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine clinical trial (NCT04396574). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the study visits involve and how often will they occur?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine clinical trial (NCT04396574). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if my child experiences side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine clinical trial (NCT04396574). Contact the study team or your healthcare provider for specific answers.

Question 5

How will the effectiveness of the treatment be measured?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine clinical trial (NCT04396574). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine clinical trial (NCT04396574). Contact the study team or your healthcare provider for specific answers.

What this study is about